Product Images Procainamide Hydrochloride
View Photos of Packaging, Labels & Appearance
- Procainamide-SPL-Container-Label-100mg - procainamide spl container label 100mg
- Procainamide-SPL-Container-Label-500mg - procainamide spl container label 500mg
- procainamide-spl-inner-carton-label-100mg - procainamide spl inner carton label 100mg
- procainamide-spl-outer-carton-label-100mg - procainamide spl outer carton label 100mg
- procainamide-spl-outer-carton-label-500mg - procainamide spl outer carton label 500mg
- procainamide-spl-structure - procainamide spl structure
Product Label Images
The following 6 images provide visual information about the product associated with Procainamide Hydrochloride NDC 68083-603 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Procainamide-SPL-Container-Label-100mg - procainamide spl container label 100mg

This is a product description for Procainamide Hydrochloride Injection, USP, in a 1 gram/10 mL multiple-dose vial. Each milliliter contains Procainamide Hydrochloride 100 mg, methylparaben 1 mg as a preservative, and sodium metabisulfite 0.8 mg. It may also contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The injection should not be used if it is darker than slightly yellow or shows any discoloration. It is advised to store the product at temperatures between 20°C to 25°C (68°F to 77°F). The manufacturer is Gland Pharma Limited located in Hyderabad, India. The product contains metabisulfites and has a specific lot/expiration date for reference.*
Procainamide-SPL-Container-Label-500mg - procainamide spl container label 500mg

This text provides information about Procainamide Hydrochloride Injection, USP, with each 2 mL vial containing 1 gram of the solution (500 mg/mL). The injection contains procainamide hydrochloride, methylparaben as preservative, and sodium metabisulfite. It is manufactured by Gland Pharma Limited in India. The product may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The storage instructions include keeping it at 20°C to 25°C [68°F to 77°F]. Additionally, there is a warning that the injection contains metabisulfites.*
procainamide-spl-inner-carton-label-100mg - procainamide spl inner carton label 100mg

This is a description of Procainamide Hydrochloride Injection, USP, with a concentration of 1 gram per 10 mL (100 mg/mL). It is indicated for intramuscular or intravenous use. The drug contains metabisulfites and preservatives. It is a sterile, nonpyrogenic solution. The text also provides information on storage conditions, dosage guidance, and warnings related to the appearance of the solution. The product is manufactured by Gland Pharma Limited in India.*
procainamide-spl-outer-carton-label-100mg - procainamide spl outer carton label 100mg

This is a description of Procainamide Hydrochloride Injection, USP. It is available in multiple-dose vials containing 1 gram/10 mL (100 mg/mL) of the medication. Each milliliter of the solution contains procainamide hydrochloride along with other additives. The medication is stored between 20°C to 25°C. It is important to follow aseptic technique while using the injection and to check for discoloration before administration. The vials contain metabisulfites and are manufactured by Gland Pharma Limited.*
procainamide-spl-outer-carton-label-500mg - procainamide spl outer carton label 500mg

This is a product description for Procainamide Hydrochloride Injection, USP. It is available in 1 gram/2 mL vials and contains Melabisulfites. The product comes with a warning and instructions for use. Customers are advised to store the product at a controlled room temperature.*
procainamide-spl-structure - procainamide spl structure

This is a chemical formula for a compound with a molecular weight of 271.79 g/mol. The compound appears to contain elements such as nitrogen, oxygen, carbon, and hydrogen. The presence of HCl suggests that this compound may be a salt formed by reacting the compound with hydrochloric acid.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.